Search research articles
Contact Us
Filters
Showing results (131-140 of 269) with videos related to
Page
of 27
Sort By:
Translational Andrology and Urology
|
July 18, 2020
Serum and tissue syndecan-1 levels in renal cell carcinoma
Christian Niedworok, Carsten Kempkensteffen, Andreas Eisenhardt, et al.
Biomedicines
|
March 25, 2022
Elevated Pre-Treatment Serum MMP-7 Levels Are Associated with the Presence of Metastasis and Poor Survival in Upper Tract Urothelial Carcinoma
Petra Terézia Kovács, Tamás Mayer, Anita Csizmarik, et al.
BJU International
|
October 13, 2017
Multicentre evaluation of magnetic resonance imaging supported transperineal prostate biopsy in biopsy-naïve men with suspicion of prostate cancer
Nienke L Hansen, Tristan Barrett, Claudia Kesch, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 11, 2017
Prostate Cancer Molecular Imaging Standardized Evaluation (PROMISE): Proposed miTNM Classification for the Interpretation of PSMA-Ligand PET/CT
Matthias Eiber, Ken Herrmann, Jeremie Calais, et al.
Cancer Reports (Hoboken, N.J.)
|
December 28, 2024
Short-Term Urinary Incontinence After Radical Prostatectomy Is Still Based on Patients' Age, Nerve-Sparing Approach, and Surgical-Experience, Despite the Higher-Use of Robotic Surgery in 2022 Compared to 2016 Real-World Results of a Large Rehabilitation Center in Germany
Lukas Püllen, Max Naumann, Ulrich Krafft, et al.
Current Oncology (Toronto, Ont.)
|
January 20, 2023
Is an Endorectal Balloon Beneficial for Rectal Sparing after Spacer Implantation in Prostate Cancer Patients Treated with Hypofractionated Intensity-Modulated Proton Beam Therapy? A Dosimetric and Radiobiological Comparison Study
Dalia Ahmad Khalil, Jörg Wulff, Danny Jazmati, et al.
Diagnostics (Basel, Switzerland)
|
October 29, 2020
Soluble Syndecan-1 Levels Are Associated with Survival in Platinum-Treated Bladder Cancer Patients
Csilla Olah, Stephan Tschirdewahn, Michèle J Hoffmann, et al.
Theranostics
|
October 3, 2025
Transcriptomic Profiling of the Tumor Immune Microenvironment Reveals Prognostic Markers in mCRPC Patients Treated with LuPSMA Therapy
Analena Handke, Leonor Lopes, Claudia Kesch, et al.
Urologic Oncology
|
April 10, 2018
Circulating syndecan-1 is associated with chemotherapy-resistance in castration-resistant prostate cancer
Tibor Szarvas, Sabina Sevcenco, Orsolya Módos, et al.
International Urology and Nephrology
|
November 24, 2021
Clinical outcome and quality of life in octogenarian patients with muscle-invasive urothelial carcinoma of the bladder treated with radical cystectomy or transurethral resection of the bladder tumor: a retrospective analysis of 143 patients
Christian Rehme, Beatrix Fritsch, Luca Thomas, et al.
Page
of 27
Search research articles
Search
Showing results (131-140 of 269) with videos related to
Sort By:
Page
of 27
Translational Andrology and Urology
|
July 18, 2020
Serum and tissue syndecan-1 levels in renal cell carcinoma
Christian Niedworok, Carsten Kempkensteffen, Andreas Eisenhardt, et al.
Biomedicines
|
March 25, 2022
Elevated Pre-Treatment Serum MMP-7 Levels Are Associated with the Presence of Metastasis and Poor Survival in Upper Tract Urothelial Carcinoma
Petra Terézia Kovács, Tamás Mayer, Anita Csizmarik, et al.
BJU International
|
October 13, 2017
Multicentre evaluation of magnetic resonance imaging supported transperineal prostate biopsy in biopsy-naïve men with suspicion of prostate cancer
Nienke L Hansen, Tristan Barrett, Claudia Kesch, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 11, 2017
Prostate Cancer Molecular Imaging Standardized Evaluation (PROMISE): Proposed miTNM Classification for the Interpretation of PSMA-Ligand PET/CT
Matthias Eiber, Ken Herrmann, Jeremie Calais, et al.
Cancer Reports (Hoboken, N.J.)
|
December 28, 2024
Short-Term Urinary Incontinence After Radical Prostatectomy Is Still Based on Patients' Age, Nerve-Sparing Approach, and Surgical-Experience, Despite the Higher-Use of Robotic Surgery in 2022 Compared to 2016 Real-World Results of a Large Rehabilitation Center in Germany
Lukas Püllen, Max Naumann, Ulrich Krafft, et al.
Current Oncology (Toronto, Ont.)
|
January 20, 2023
Is an Endorectal Balloon Beneficial for Rectal Sparing after Spacer Implantation in Prostate Cancer Patients Treated with Hypofractionated Intensity-Modulated Proton Beam Therapy? A Dosimetric and Radiobiological Comparison Study
Dalia Ahmad Khalil, Jörg Wulff, Danny Jazmati, et al.
Diagnostics (Basel, Switzerland)
|
October 29, 2020
Soluble Syndecan-1 Levels Are Associated with Survival in Platinum-Treated Bladder Cancer Patients
Csilla Olah, Stephan Tschirdewahn, Michèle J Hoffmann, et al.
Theranostics
|
October 3, 2025
Transcriptomic Profiling of the Tumor Immune Microenvironment Reveals Prognostic Markers in mCRPC Patients Treated with LuPSMA Therapy
Analena Handke, Leonor Lopes, Claudia Kesch, et al.
Urologic Oncology
|
April 10, 2018
Circulating syndecan-1 is associated with chemotherapy-resistance in castration-resistant prostate cancer
Tibor Szarvas, Sabina Sevcenco, Orsolya Módos, et al.
International Urology and Nephrology
|
November 24, 2021
Clinical outcome and quality of life in octogenarian patients with muscle-invasive urothelial carcinoma of the bladder treated with radical cystectomy or transurethral resection of the bladder tumor: a retrospective analysis of 143 patients
Christian Rehme, Beatrix Fritsch, Luca Thomas, et al.
Page
of 27